Navidea shareholders reject 1-for-20 reverse stock split, don't endorse director nominees
July 03, 2017 at 12:40 PM EDT
Shareholders resoundingly knocked down a proposed 1-for-20 reverse stock split for Dublin-based Navidea Biopharmaceuticals Inc., leaving the company to find another way to prop up its sagging share price.
